Navigation Links
BD Increases Haiti Relief Fund to Include $5 Million in Product Donations
Date:1/27/2010

FRANKLIN LAKES, N.J., Jan. 27 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, is increasing the supply of its products available for donation in support of Haiti earthquake relief efforts from the $500,000 announced on January 15 to $5 million in market value of critical medical supplies.  This additional commitment will help BD's nonprofit partner organizations use and provide BD products they have specifically requested to address the healthcare disaster and ongoing needs in Haiti.

BD regularly pre-positions product donations with AmeriCares, Catholic Medical Mission Board, Direct Relief International, Heart to Heart International and Project HOPE to enable these nonprofit organizations to respond swiftly in disaster situations around the world, such as the Haiti earthquake.  To date, these groups have distributed I.V. catheters, antimicrobial scrub brushes and antiseptic, needles and syringes, and various other BD products in Haiti. BD will continue to work with these nonprofit agencies as they conduct ongoing needs assessments for critical products.

This increase in BD's product donation commitment augments the $1.2 million fund BD initially established for Haiti relief efforts and brings the total to $5.7 million. In addition to products, as previously announced, BD is donating $550,000 in cash to nine humanitarian aid partner organizations (American Red Cross, AmeriCares, Catholic Medical Mission Board, Direct Relief International, Heart to Heart International, Partners In Health, Project HOPE, Save the Children and the U.S. Fund for UNICEF) and matching up to $150,000 in donations from BD associates worldwide to the U.S. Fund for UNICEF; this match is in addition to BD's traditional Matching Gift Program.

As a member of the Partnership for Quality Medical Donations, BD is distributing its donations among its pre-approved nonprofit partners, which share a commitment to the World Health Organization's guidelines on appropriate product donation practices.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

SOURCE BD (Becton, Dickinson and Company)

RELATED LINKS
http://www.bd.com

'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics Announces Increases in Pre-tax Profits and Net Income for the Quarter Ended December 31, 2009
2. Hanger Orthopedic Group Increases Q4 2009 Sales and EPS Guidance
3. CVS Caremark Corporation Increases Quarterly Dividend 15%
4. EvoLucia(TM) LED Lighting Saves Energy, Increases Security at Sarasota Hospital
5. WellTek Subsidiary MedX Limited Increases Presence in Global Market
6. ScandiDos Sells 100th Delta4(R) PT Unit as Adoption of Rotational Therapy Cancer Treatment Increases
7. Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients
8. Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
9. West Increases Quarterly Dividend to $0.16
10. ReBuilder Medical Technologies, Inc. Hiring! Increases Staff by 40%
11. New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Australie, le 24 février 2017 ITL Limited, ( ... diversifiée innovante, est ravie d,annoncer les excellents résultats semestriels ... période précédente correspondante. Une présentation complète « Résultats et mise ... consultée ici . Faits marquants ... 2,12 millions $ (Déc. 2015 : 1,04 million $ ; en hausse de 104 %) ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an ... that it has acquired exclusive worldwide rights to ... innovative HDAC inhibitor targeting hematological and solid tumors. ... Phase 1 and 2 clinical trials of Abexinostat ... have already been completed, demonstrating that Abexinostat ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... The California State University ... academic faculty engaged in or interested in palliative care education and research. The Symposium, ... held in North County San Diego on Sept. 28 and 29, 2017, on the ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Indiana Fiber ... from the company later this year. Dyer started as the Chairman of the ... for the establishment of the corporation including the recruitment of investor/owners and development of ...
(Date:2/24/2017)... ... 24, 2017 , ... Congratulations to Head Over Heels’ elite ... 12th. Ms. Esparza qualified into this prestigious status after winning the Vault, ... Vegas, Nevada. Frida is one of approximately 25 gymnasts in the nation who ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February 22, ... a letter to withdraw previous guidance issued by the Obama Administration requiring ... issued in May 2016 by the Obama Administration came in response to a ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, which ... participating in Rare Disease Day events, hosted by the Rare Disease Legislative Advocates ... a website, weekly e-newsletter and quarterly publication, will be conducting interviews with patients ...
Breaking Medicine News(10 mins):